Bend the cost curve in oncology and cardiology.
Managing the cost of specialty care doesn’t require abrasive physician oversight. Our holistic approach to specialty benefit management consistently drives over 7% immediate savings, 50% ongoing trend reduction and the highest levels of quality and physician satisfaction.
Hear from Dr. Jeffrey Ward, Oncologist-Hematologist with Swedish Cancer Institute and New Century Health CEO Dan McCarthy about what makes our model unique.
How Real-World Evidence Can Transform High-Value Oncology Pathways
Our CMO Dr. Andrew Hertler explains how real-world evidence may usher in the next generation of oncology clinical pathways.
Controlling Total Cost of Care in Oncology: 3 Areas Where Health Plans Should Focus
Discover value-based payment strategies and tools to help oncologists improve care across the patient journey.
The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care
Our Scientific Advisory Board shares takeaways from how practices are adapting to care for a vulnerable population.
High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.
Driving Culture Change In The Pursuit Of Value:
Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.
Creating A “Culture Of Yes” In Prior Authorization
Prior authorization is a major source of frustration for providers. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.
Cancer Care During COVID-19: How to Navigate New Risks
Read insights for minimizing patients’ risk of COVID-19 when their cancer therapies cannot be delayed.
Cancer Costs Everyone Too Much. Here’s How We Fix It.
Read how the deployment of evidence-based clinical pathways improve patient outcomes while decreasing waste and cost.
Get In Touch With New Century Health
Please select the purpose for your request.